Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Cancers|September 19, 2020
Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast CancerBruna Cerbelli, Simone Scagnoli, Silvia Mezi, et al.
Cancers|September 28, 2023
The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic MelanomaSilvia Mezi, Andrea Botticelli, Simone Scagnoli, et al.
Frontiers in Oncology|November 29, 2023
Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective studyFabrizio Nelli, Agnese Fabbri, Andrea Botticelli, et al.
Recenti Progressi in Medicina|July 1, 2023
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]Gabriele Minuti, Alessio Stefani, Luca Trodella, et al.
Frontiers in Immunology|November 21, 2022
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapyAndrea Botticelli, Giulia Pomati, Alessio Cirillo, et al.
Oncology|December 7, 2021
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?Alessandra Fabi, Mariangela Ciccarese, Sinome Scagnoli, et al.
The Oncologist|January 26, 2026
Clinical characteristics and Drug-Drug interactions in HER2+ breast cancer treated with T-DXd: Real-World data from the DE-REAL studySimona Pisegna, Simone Scagnoli, Gabriella Gentile, et al.
Cancer Immunology, Immunotherapy : CII|March 3, 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approachAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Cancers|August 27, 2021
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, et al.
NPJ Precision Oncology|January 22, 2025
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab DeruxtecanAlessandra Fabi, Alessandro Rossi, Roberta Caputo, et al.
Pageof 4